ICHS Members: Complimentary
Please log in first to register as a member.
Non-members: $25USD - includes a one year ICHS membership
Exciting online session from ICHS offering education about the new advances in CMV management! This session will be based on the needs assessment results and the most up to date research.
This webinar will provide dynamic, interactive content on the latest updates on CMV infections from updated guidelines to the utility of measuring CMV T Cell immunity to the burden of CMV post cellular therapy, based on needs assessments and questions from the attendees. The goal is to offer the following objectives and a comprehensive scientific session with insights into cutting-edge research, innovative care practices, updated guidelines, and Q&A opportunities with a diverse range of experts.
Objectives:
- Learn from the co-chair of the ECIL guidelines for CMV about the latest changes made since the last update.
- Understand the role of CMV T Cell Immunity in mitigating the risk of CMV infections in Allogeneic Cell Transplant recipients.
- Learn about the latest updates on risk of CMV infections after cellular therapy and its impact on oncologic outcomes.
This webinar will offer ample time for Q&A with the experts.
Meet the Speakers:
Rafael de la Cámara, MD
Faculty Member, Hematology
Hospital de la Princesa
Hospital Universitario De La Princesa
Faculty Member
Hospital de la Zarzuela
Madrid, Spain
Joshua A. Hill, MD
Associate Professor, Department of Medicine, Division of Allergy and Infectious Diseases
University of Washington Medical Center
Assistant Professor, Vaccine and Infectious Disease Division, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington USA
Michelle K. Yong, MBBS, FRACP, MPH, PhD
Infectious Diseases Physician
University of Melbourne
Peter MacCallum Cancer Centre
Melbourne, Australia
